表紙:マルファン症候群:世界の治験動向
市場調査レポート
商品コード
1003459

マルファン症候群:世界の治験動向

Marfan Syndrome - Global Clinical Trials Review, H1, 2021

出版日: | 発行: GlobalData | ページ情報: 英文 38 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.86円
マルファン症候群:世界の治験動向
出版日: 2021年04月30日
発行: GlobalData
ページ情報: 英文 38 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、マルファン症候群の治験に関連する基本情報やデータを提供しており、先進7か国(G7)の試験件数および被験者の募集状況、段階別の動向、治験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

目次

  • レポートガイダンス
  • 調査範囲
  • 各地域の治験件数
  • 試験件数と平均被験者数
  • マルファン症候群治療薬:主要国の進行中の治験
  • 欧州の主要治験5ヶ国
  • 北米の主要治験上位国
  • G7諸国の治験件数:遺伝子疾患治験におけるマルファン症候群の割合
  • G7諸国の治験件数:段階別
  • G7諸国の治験件数:治験状況別
  • 治験件数:段階別
  • 治験件数:治験状況別
  • 治験件数:エンドポイント状況別
  • 治験件数:スポンサー種類別
  • 主要スポンサー
  • マルファン症候群治療薬の治験に参加する上位企業
  • 治験のプロファイル

付録

  • 略語
  • 定義
  • 調査手法
  • 2次調査
  • GlobalDataについて
  • お問い合わせ
  • 出典
図表

List of Tables

List of Tables

  • Marfan Syndrome Therapeutics, Global, Clinical Trials by Region, 2021*
  • Marfan Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Marfan Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2021*
  • Marfan Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2021*
  • Marfan Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2021*
  • Proportion of Marfan Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2021*
  • Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Marfan Syndrome Therapeutics, Global, Clinical Trials by Phase, 2021*
  • Marfan Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Marfan Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Marfan Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2021*
  • Marfan Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Marfan Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*

List of Figures

List of Figures

  • Marfan Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2021*
  • Marfan Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Marfan Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2021*
  • Marfan Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2021*
  • Marfan Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2021*
  • Proportion of Marfan Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2021*
  • Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Marfan Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2021*
  • Marfan Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Marfan Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Marfan Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2021*
  • Marfan Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Marfan Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • GlobalData Methodology
目次
Product Code: GDHC6667CTIDB

GlobalData's clinical trial report, "Marfan Syndrome - Global Clinical Trials Review, H1, 2021" provides an overview of Marfan Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Marfan Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Marfan Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Marfan Syndrome to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Marfan Syndrome Therapeutics Clinical Trials
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source